Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Department of Medical Genetics, |
RCV001291942 | SCV001480481 | pathogenic | Mucopolysaccharidosis, MPS-II | criteria provided, single submitter | clinical testing | ||
Revvity Omics, |
RCV001291942 | SCV003825301 | pathogenic | Mucopolysaccharidosis, MPS-II | 2021-12-29 | criteria provided, single submitter | clinical testing | |
Neuberg Centre For Genomic Medicine, |
RCV001291942 | SCV004100443 | pathogenic | Mucopolysaccharidosis, MPS-II | criteria provided, single submitter | clinical testing | The splice acceptor variant c.1181-1G>C in IDS (NM_000202.8) has been reported previously in an affected patient (Amartino H et al). It has submitted to ClinVar as Pathogenic. The c.1181-1G>C variant is novel (not in any individuals) in gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes. This variant affects an invariant splice nucleotide. Though it is present in the last exon, it has been classified as Pathogenic as it has been reported previously in similarly affected patients. | |
Laboratory of Diagnosis and Therapy of Lysosomal Disorders, |
RCV001291942 | SCV005089459 | pathogenic | Mucopolysaccharidosis, MPS-II | 2024-06-07 | criteria provided, single submitter | literature only | Null variant (PVS1_Strong), Absent from controls (or at low frequency) in gnomAD database (PM2_Moderate), Patient’s phenotype or family history highly specific for the disease (PP4_Strong) |